Pradaxa 110 mg Capsule

Pradaxa 110 mg Capsule is a prescription anticoagulant that contains 110 mg of dabigatran etexilate in each capsule. It belongs to the direct thrombin inhibitor class, which helps reduce the risk of harmful blood clots. Doctors prescribe Pradaxa 110 mg Capsule for selected adults who need blood clot prevention or treatment based on their medical history and bleeding risk. It is not a pain reliever and it does not dissolve an existing clot right away.

How it works: Dabigatran etexilate is converted in the body to dabigatran, which blocks thrombin, a key clotting enzyme. In capsule form, Pradaxa 110 mg Capsule is swallowed whole so the medicine can be absorbed and then begin helping prevent clot formation.

Pradaxa 110 mg Capsule is a higher-strength option than the 75 mg capsule, but it is lower than the 150 mg capsule. A doctor may choose Pradaxa 110 mg Capsule when a patient needs anticoagulation but may benefit from a more cautious dose based on kidney function, age, bleeding risk, or other clinical factors. The effect is not felt like a stimulant or sedative; instead, it works quietly to lower clotting ability over time.

• Reduce stroke risk in atrial fibrillation
• Treat and help prevent deep vein thrombosis (DVT)
• Treat and help prevent pulmonary embolism (PE)
• Prevent clots after certain surgery when prescribed
• Lower the chance of clot-related complications in selected patients

• Swallow Pradaxa 110 mg Capsule whole with a full glass of water.
• Do not open, crush, break, or chew the capsule.
• Take it exactly as prescribed, usually at the same times each day.
• You may take it with or without food.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose; do not double up.
• Keep the capsules in the original packaging until use, because the bottle/blister protection matters for this medicine.

Each Pradaxa 110 mg Capsule provides 110 mg of dabigatran etexilate, and the doctor decides how often it should be taken. Depending on the condition being treated and your kidney function, it may be prescribed once daily or, more commonly, twice daily; do not take more than the amount your prescriber recommends. The exact dose and duration are individualized, and some patients need a lower or higher strength instead of Pradaxa 110 mg Capsule.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Dabigatran Etexilate may include:

• Bleeding more easily than usual
• Upset stomach or indigestion
• Stomach pain
• Nausea
• Bruising
• Headache

• Pradaxa 110 mg Capsule increases bleeding risk, so tell your doctor about any history of ulcers, stomach bleeding, or bleeding disorders.
• This strength should be used only when a clinician has checked kidney function and overall clotting/bleeding risk.
• Do not stop Pradaxa 110 mg Capsule on your own, because stopping suddenly can raise the risk of stroke or clots.
• Use caution with alcohol, which can increase bleeding risk and stomach irritation.
• Tell surgeons, dentists, and emergency clinicians that you take dabigatran before any procedure.
• Avoid taking other medicines that increase bleeding unless your doctor specifically approves them.
• If you have trouble swallowing capsules, ask your doctor before changing the dosage form; do not open the capsule.

• Aspirin and other NSAIDs such as ibuprofen or naproxen
• Other anticoagulants, including heparin, warfarin, or apixaban unless specifically directed
• Clopidogrel, ticagrelor, and similar antiplatelet medicines
• Strong P-gp interacting medicines such as dronedarone, ketoconazole, and rifampin
• SSRIs or SNRIs, which can add to bleeding risk

Store Pradaxa 110 mg Capsule in the original package at room temperature, protected from moisture, and keep the pack tightly closed until ready to use.